Further preclinical studies are required to investigate the pathophysiology of novel zoonotic outbreaks such as COVID19, SARS, or MERS, which remains poorly understood.
This document provides extensive information on providing detailed insight into lung inflammatory responses including:
- Airway hyperresponsiveness assessment upon infection
- Lung physiology assessment upon infection
- Drug delivery and therapeutics assessment
